:

What is the controversy with Fosamax?

Originally approved in 1995, Fosamax, a bisphosphonate used to treat osteoporosis, was once considered a breakthrough treatment. However, a series of adverse event reports and lawsuits have ignited the controversy with Fosamax regarding its long-term safety and manufacturer warnings.